☆ 4.6 Article

A novel compound heterozygous variant in ALPK3 induced hypertrophic cardiomyopathy: a case report

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Review Cardiac & Cardiovascular Systems

Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies

Roddy Walsh et al.

Summary: This review explores the complex contribution of genes encoding non-sarcomeric proteins associated with non-syndromic or isolated hypertrophic cardiomyopathy to the genetics of cardiomyopathies. The study highlights the role of various genes in the pathogenesis of cardiomyopathies and the overlapping genetic basis between hypertrophic cardiomyopathy and dilated cardiomyopathy. This overlap extends to rare Mendelian variants with distinct variant classes in several genes associated with both types of cardiomyopathy.

NATURE REVIEWS CARDIOLOGY (2022)

Add to Collection

Article Genetics & Heredity

Case Report: A Chinese Family of Hypertrophic Cardiomyopathy Caused by a Novel Splicing Mutation in the FLNC Gene

Chunhui Huang et al.

Summary: We reported the first case of familial hypertrophic cardiomyopathy caused by a novel FLNC splicing mutation in China. Duo exome sequencing revealed a heterozygous mutation in the FLNC gene as a potential cause of autosomal dominant HCM. Treatment with furosemide, spironolactone, and metoprolol improved the patient's heart function and alleviated symptoms.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Medicine, General & Internal

Genetic Evaluation of Late-Onset Hypertrophic Cardiomyopathy: An Autobiographical Case Report

Simon Carlo et al.

Summary: This article reports a case of late-onset hypertrophic cardiomyopathy and identifies two variants of uncertain significance through genetic testing. It sheds light on the importance of genetic screening in understanding the etiology of clinical symptoms.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Recent Findings Related to Cardiomyopathy and Genetics

Takanobu Yamada et al.

Summary: Advancements in NGS have made genetic analysis more accessible, leading to discoveries about the role of rare variants in cardiomyopathy and the variability of clinical courses based on causative genes. These findings extend beyond traditional types of cardiomyopathy to include conditions like PPCM, CTRCD, and ACM, sparking progress in understanding mechanisms and developing new therapies. Recent studies also suggest a contribution of common variants in cardiomyopathy development, marking a new era in the field of cardiomyopathy and genetics.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Genetic Testing in Patients with Hypertrophic Cardiomyopathy

Jiri Bonaventura et al.

Summary: Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with complex genetic basis involving mutations in multiple genes. Patients without pathogenic variants are now believed to have non-Mendelian HCM and may have a better prognosis. Identifying the genetic basis of HCM provides opportunities for understanding disease development and potential interventions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies

Hiroaki Kitaoka et al.

CIRCULATION JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

Luis R. Lopes et al.

Summary: The study identified a low but pathogenic frequency of heterozygous ALPK3tv in patients with HCM, which was confirmed through family co segregation studies. ALPK3tv carriers exhibited a characteristic HCM phenotype, showing different clinical and imaging features compared to patients with sarcomere gene variants.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

Luis R. Lopes et al.

Summary: The study aimed to determine the frequency of heterozygous truncating ALPK3 variants in patients with hypertrophic cardiomyopathy (HCM) and confirm their pathogenicity through burden testing. The results showed that ALPK3tv carriers had a higher prevalence of apical/concentric patterns of hypertrophy and a short PR interval, indicating a characteristic HCM phenotype. Patients with ALPK3tv also had higher rates of heart failure or cardiac transplantation, with imaging and histopathology revealing extensive myocardial fibrosis and myocyte vacuolation.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants

Johanna C. Herkert et al.

AMERICAN HEART JOURNAL (2020)

Add to Collection

Article Genetics & Heredity

Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants

John Jorholt et al.

GENES (2020)

Add to Collection

Article Medical Laboratory Technology

Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathy

Andreas Brodehl et al.

TRANSLATIONAL RESEARCH (2019)

Add to Collection

Article Genetics & Heredity

Phenotypic spectrum of ALPK3-related cardiomyopathy

Khalfan Al Senaidi et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Hypertrophic Cardiomyopathy

Jeffrey B. Geske et al.

JACC-HEART FAILURE (2018)

Add to Collection

Article Genetics & Heredity

Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features

Hager Jaouadi et al.

JOURNAL OF HUMAN GENETICS (2018)

Add to Collection

Article Medicine, Research & Experimental

ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features

Ahmet Okay Caglayan et al.

COLD SPRING HARBOR MOLECULAR CASE STUDIES (2017)

Add to Collection

Review Genetics & Heredity

Molecular genetics and pathogenesis of cardiomyopathy

Akinori Kimura

JOURNAL OF HUMAN GENETICS (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathyaEuro

Dean G. Phelan et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy Insights From Wave Intensity Analysis and Magnetic Resonance

Claire E. Raphael et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy

Rowida Almomani et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)

Perry M. Elliott et al.

EUROPEAN HEART JOURNAL (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High-Risk Population

Konstantinos C. Siontis et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Add to Collection

Article Pathology

Cardiomyopathy in alpha-Kinase 3 (ALPK3)-Deficient Mice

I. Van Sligtenhorst et al.

VETERINARY PATHOLOGY (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Bernard J. Gersh et al.

CIRCULATION (2011)

Add to Collection

Review Medicine, General & Internal

The development of familial hypertrophic cardiomyopathy: from mutation to bedside

Wessel P. Brouwer et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)

Add to Collection

Review Biochemistry & Molecular Biology

The alpha-kinase family: an exceptional branch on the protein kinase tree

Jeroen Middelbeek et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2010)

Add to Collection

Review Cardiac & Cardiovascular Systems

Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy

J. Martijn Bos et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

Perry Elliott et al.

EUROPEAN HEART JOURNAL (2008)

Add to Collection

Article Biochemistry & Molecular Biology

A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes

T Hosoda et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.